HIV Clinical Nurse Specialist CCDHB Wellington

Similar documents
treatment passport 1

The Future of HIV: Advances in Drugs and Research. Shauna Gunaratne December 17, 2018

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

0% 0% 0% Parasite. 2. RNA-virus. RNA-virus

HIV Drugs and the HIV Lifecycle

Antiretroviral Dosing in Renal Impairment

Overview of HIV WRAIR- GEIS 'Operational Clinical Infectious Disease' Course

Overview of HIV. LTC Paige Waterman

Nothing to disclose.

ART and Prevention: What do we know?

Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care

OB/GYN CHART REVIEW DRAFT: NOT FOR DISTRTIBUTION

Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications

Third Agent Advantages Disadvantages. Component Tenofovir/emtricitabine (TDF/FTC) 300/200 mg (coformulated with EFV as Atripla) 1 tab once daily

An HIV Update Jan Clark, PharmD Specialty Practice Pharmacist

Midwestern Underwriting Conference 2016

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Selecting an Initial Antiretroviral Therapy (ART) Regimen

HIV Management Update 2015

Nobel /03/28. HIV virus and infected CD4+ T cells

HIV and Common Comorbidities August 17, Michael MacVeigh, MD & Kristen Meyers, BS, CADC1

CLAUDINE HENNESSEY & THEUNIS HURTER

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

Continuing Education for Pharmacy Technicians

WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

Optimizing 2 nd and 3 rd Line Antiretroviral Therapy in Children and Adolescents

HIV Pharmacology 101ish - 202ish: New HIV Clinicians Workshop

HIV Treatment Guidelines

Pediatric HIV Infection and the Medical Management of Pregnant Women infected with HIV. Ernesto Parra, M.D., M.P.H.

ARV Consolidated Guidelines 2015

Approach to a Patient Newly Diagnosed with HIV, Including ART Basics Rajesh T. Gandhi, M.D.

Simplifying HIV Treatment Now and in the Future

The use of antiretroviral agents during pregnancy in Canada and compliance with North-American guidelines

HIV medications HIV medication and schedule plan

Principles of Antiretroviral Therapy

Starting Immediate Treatment for HIV-1

HIV and contraception the latest recommendations

Comprehensive Guideline Summary

Overview of HIV. Christina Polyak, MD, MPH. Research Physician. U.S. Military HIV Research Program, Walter Reed Army Institute of Research

2016 Perinatal Treatment Guidelines Update

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING**, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

A Fatal Imbalance. Tropical diseases: 18 new drugs (incl. 8 for malaria) 1.3% 21 new drugs for neglected diseases. Tuberculosis: 3 new drugs

ANTIRETROVIRAL TREATMENTS (Part 1of

Pediatric HIV Update NORTHWEST AIDS EDUCATION AND TRAINING CENTER

Antiretroviral Treatment Strategies: Clinical Case Presentation


SOUTH FLORIDA SE AIDS EDUCATION & TRAINING CENTER. HIV and Oral Health in the Era of Antiretroviral Therapy

HIV/AIDS Prenatal Care for HIV+ Mothers. 1. Algorithm for Prenatal Screening & Care (Antepartum)

Management of HIV Infected Children and Adolescents: Public Sector Approach in Kenya

Didactic Series. CROI 2014 Update. March 27, 2014

Biomedical / Medical / Treatment Update - December 3, 2014

Matters of the HAART: An Update on Current Treatment Options for HIV

HIV and YOU. Special 2008 Update!

Blood-Borne Pathogens and Post-Exposure Prophylaxis

Exploring HIV in 2017: What a pharmacist needs to know

HIV-1-infected Males and Females under Less-Drug Regimens Achieve Antiretroviral Levels above the Inhibitory Concentration in the Genital Tract.

PHCP 403 by L. K. Sarki

treatment VIRAL SUPPRESSION SUPPORT ART IS THE ONLY WAY TO CONTROL HIV TIPS FOR TAKING ART ADHERENCE Benefits of ART Start Know Your ARVs today ARVs

Genotyping and Drug Resistance in Clinical Practice. Case Studies

Overview of HIV WRAIR- GEIS 'Operational Clinical Infectious Disease' Course

Sculpting a Better Regimen: The ART of HIV Medications

Approach for the Newly Diagnosed HIV Positive Patient

PrE-Exposure Prophylaxis (PrEP) A Tool at Your Hand to Fight HIV

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist

PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV

HIV for the Non-ID Pharmacist

Human Immunodeficiency Virus (HIV)

HIV basics. Katya Calvo Medical Director of Antimicrobial Stewardship

What's new in the WHO ART guidelines How did markets react?

Clinical skills building - HIV drug resistance

I. HIV Epidemiology. HIV Infection A Primer. Objectives. Disclosures 7/18/2014

BHIVA guidelines on the treatment of HIV-1-positive adults with antiretroviral therapy. START & other changes

Addressing Pediatric Needs of the Most Neglected: next steps

Pharmacological considerations on the use of ARVs in pregnancy

The ART of Managing Drug-Drug Interactions in Patients with HIV

HIV Update. Divya Ahuja, MD Associate Professor of Medicine University of South Carolina School of Medicine

Principle of ART. HIV treatment experience in Latvia. Patient centered health care. How to improve adherence to ART? HIV and TB co-infection in Latvia

This graph displays the natural history of the HIV disease. During acute infection there is high levels of HIV RNA in plasma, and CD4 s counts

HIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options

The Eras of the HIV Epidemic

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

Antiretrovial Crushable/Liquid Formulation Chart

When to Start ART. Reduction in HIV transmission. ? Reduction in HIV-associated inflammation and associated complications» i.e. CV disease, neuro, etc

Projeto Praça Onze Universidade Federal do Rio de Janeiro. Long term treatment of chronic viral disease: lessons from HIV for HBV

Case # 1. Case #1 (cont d)

Antiretroviral Drugs

Susan L. Koletar, MD

BHIVA antiretroviral treatment guidelines 2015

HIV in in Women Women

WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM

October 26-28: Training Day 1

Antiretroviral Pregnancy Registry

PRO 140. First self-administered antibody therapy for HIV in late-stage clinical development. March

HIV 101. Applications of Antiretroviral Therapy

TRANSPARENCY COMMITTEE

New Frontiers for Treatment Strategies for HIV Care

JULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet

Jonathan Cohn MD Wayne State University July 24,

HIV Treatment: New and Veteran Drugs Classes

Transcription:

RN James Rice-Davies HIV Clinical Nurse Specialist CCDHB Wellington 11:00-11:55 WS #88: Undiagnosed HIV in Your Practice 12:05-13:00 WS #99: Undiagnosed HIV in Your Practice (Repeated)

HIV- Undiagnosed & in Your Care James Rice-Davies 027 444 1967 HIV Clinical Nurse Specialist CCDHB

Just Tick the Box 600 People in NZ Yet to be Found Patients will end up with a normal life expectancy

Kaposi s Sarcoma, PCP & Oral Thrush First descriptions in 1981 Seen in young otherwise healthy young men

Differential Diagnosis for HIV Weight loss/ Altered bowel habits/ fatigue on going vague Shingles (<50yrs) Persistent Skin-fungal/Eczema Glandular Like Fever (male) Enlarged Lymph Nodes Abnormal Platelets Neutrophils Oral Thrush Difficult to Tx oral herpes Just tick the box

HIV global pandemic Global HIV epidemic 78 million infected globally, 40 million deaths 38 million people living with HIV 2.1 million new infections 1.1 million deaths http://www.unaids.org/en/dataanalysis/datatools/aidsinfo/ (2015)

HIV Diagnoses in NZ are increasing

HIV

HIV Management viral suppression & immune recovery HIV VL > 1000,000 T-Helper Cell CD4 (N> 600) Hit Undetectable Viral Load (< 6 copies/ml) In 3 months on ARV Treatment Antiretroviral therapy (ART): combination of usually 3 anti-viral agents

What s the Decade here?

The Concept of Key Populations in Prevention 1) Men who have sex with men 2) People who inject drugs 3) People in prison and closed settings 4) Sex workers 5) Transgender people 6) Needlestick injuries

Let s Stop Thinking 1980 s No Pre & Post test Counseling required No Life Insurance Problems No Consent Issues If your thinking Hep A/B/C testing inc. HIV If your doing an STI screen lets inc. swabs Anal & Oral Lets do bloods for Syphilis and HIV Lets think Differential Diagnosis not Risk factors Lets just Tick the Box and rule HIV out

Who doing HIV testing? GP s - Diagnose 40% of HIV cases in New Zealand; Late into infection, Patients are unwell with a low CD4 counts, & had several sexual partners before being diagnosed New Zealand AIDS Foundation Sexual Health Clinics Family Planning Associates Prison Service

A Few Recent Cases Dr s Wife become breathless Husband becomes more and more forgetful Wife after years and years with oral sores- becomes SOB Auckland carried out an audit showing... Gay Man about to have half his bowel taken out

UNAIDS Goal 90/90/90 for 2020 World Wide Goal New Zealand 90% Diagnosed 80% Estimated 90% On ARV Treatment 89% On ARV Tx 90% Undetectable HIV Viral Load 93% Undetectable VL 20% remain undiagnosed in NZ START / Partner Study

OR Perhaps lets not talk about it! Lets just rule it out

HIV / Sexual Health Risk Factors Disclosure of information? To your GP? MSM /GBM Sexual History Male Female Both Right tests from the right place... Oral Anal Vaginal Urethral Swabs/ urine / bloods Diagnosing and treating other STI s will reduce the risk of picking up HIV

HIV Testing

Differential Diagnosis including HIV (not risk groups) Weight loss/ Altered bowel habits/ fatigue on going vague Shingles Persistent Skin-fungal/Eczema Glandular Like Fever (male) Enlarged Lymph Nodes Abnormal Platelets Neutrophils Oral Thrush Difficult to Tx oral herpes

Anti-Retroviral Therapy (ART) in New Zealand ART therapy is a cocktail of 3 medications from 2 drug classes 2 backbones + 1 third agent Two Backbones One 3 rd Agent NRTIs NNRTI PI INI CCR5 Inhibitor Single Agent NRTI: 3TC (lamivudine) Retrovir (ZDV/AZT) Ziagen (abacavir) Viread (TDF) Emtriva (FTC) Combination NRTI: Kivexa (ABC/3TC) Combivir (3TC/AZT) Truvada (FTC/TDF) ATRIPLA (FTC/TDF/EFV) Stocrin (EFV) Intelence (ETR) Nevirapine (NVP) Either one of these 3 rd Agents Prezista (DRV) Kaletra (LPV/r) Reyataz (ATV) Norvir (RTV)(booste r) Isentress (RAL) Tivicay (DTG) Not available in NZ Less problematic than Diabetes ( if offered a HIV test )

HIV lifecycle: targets for antiretroviral therapy Entry Inhibitors (EI) Integrase inhibitors (InSTI) Protease inhibitors (PI) Fusion inhibitors (EI) Reverse transcriptase inhibitors (NRTI/NNRTI) http://vsbassociates.com/images/powerpoint/2hiv-replication-cycle.jpg

HIV Viral Load; Undetectable = Untransmittable Cohen M.

Testing the Right people at the Right Time!

Why Test? Testing is the first step in maintaining a healthy life and reducing the spread of HIV CDC recommends that everyone between the ages of 13 and 64 get tested for HIV at least once as part of routine health care. Sexually active gay and bisexual men may benefit from getting an HIV test more often, perhaps every 3 to 6 months

Still in 2016 30-40% of cases present with late advanced HIV disease Before being offered a HIV test! 1981-2017 Source: http://kirby.unsw.edu.au/sites/default/files/hiv/resources/hivasrsuppl2014_online.pdf

Patients will end up with a normal life expectancy If YOU Just Tick the Box 600 People in NZ Yet to be Found